Monday 29 December 2014
 
»
Tag
 
»
Isentress

GSK's new HIV drug matches rival

A new once-daily Aids drug from GlaxoSmithKline and its partner Shionogi proved just as good as Merck & Co's twice-daily rival Isentress in a late-stage clinical trial, boosting hopes for the product. Both GSK's new drug dolutegravir a

Moreā€¦
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads